Wintrust Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $137K | Sell |
2,430
-1,504
| -38% | -$84K | 0.12% | 130 |
|
|
2024
Q3 | $203K | Sell |
3,934
-46,851
| -92% | -$2.2M | 0.15% | 128 |
|
|
2024
Q2 | $2.11M | Buy |
50,785
+11,133
| +28% | +$498K | 0.17% | 117 |
|
|
2024
Q1 | $2.15M | Buy |
39,652
+3,515
| +10% | +$179K | 0.19% | 114 |
|
|
2023
Q4 | $1.85M | Sell |
36,137
-43,289
| -55% | -$2.27M | 0.18% | 119 |
|
|
2023
Q3 | $4.61M | Sell |
79,426
-62,833
| -44% | -$3.85M | 0.48% | 40 |
|
|
2023
Q2 | $9.1M | Sell |
142,259
-25,911
| -15% | -$1.74M | 0.91% | 19 |
|
|
2023
Q1 | $11.7M | Buy |
168,170
+27,173
| +19% | +$1.92M | 1.49% | 12 |
|
|
2022
Q4 | $10.1M | Sell |
140,997
-4,474
| -3% | -$337K | 1.33% | 12 |
|
|
2022
Q3 | $10.3M | Sell |
145,471
-241
| -0.2% | -$17.5K | 1.29% | 14 |
|
|
2022
Q2 | $11.2M | Buy |
145,712
+117,692
| +420% | +$8.96M | 1.34% | 15 |
|
|
2022
Q1 | $2.05M | Buy |
28,020
+483
| +2% | +$32.4K | 0.2% | 94 |
|
|
2021
Q4 | $1.72M | Sell |
27,537
-293
| -1% | -$17.2K | 0.16% | 117 |
|
|
2021
Q3 | $1.65M | Buy |
27,830
+326
| +1% | +$21.5K | 0.22% | 84 |
|
|
2021
Q2 | $1.84M | Sell |
27,504
-193
| -0.7% | -$12.6K | 0.19% | 107 |
|
|
2021
Q1 | $1.75M | Buy |
+27,697
| New | +$1.72M | 0.18% | 114 |
|
|
2020
Q4 | – | Sell |
-28,051
| Closed | -$1.69M | – | 204 |
|
|
2020
Q3 | $1.69M | Sell |
28,051
-1,448
| -5% | -$87.2K | 0.23% | 89 |
|
|
2020
Q2 | $1.74M | Buy |
29,499
+6,493
| +28% | +$388K | 0.24% | 79 |
|
|
2020
Q1 | $1.28M | Sell |
23,006
-290
| -1% | -$17.7K | 0.21% | 84 |
|
|
2019
Q4 | $1.5M | Sell |
23,296
-1,127
| -5% | -$64.5K | 0.21% | 92 |
|
|
2019
Q3 | $1.24M | Sell |
24,423
-4,984
| -17% | -$234K | 0.18% | 98 |
|
|
2019
Q2 | $1.33M | Sell |
29,407
-36,476
| -55% | -$1.7M | 0.2% | 94 |
|
|
2019
Q1 | $3.14M | Sell |
65,883
-1,117
| -2% | -$55.6K | 0.51% | 39 |
|
|
2018
Q4 | $3.48M | Sell |
67,000
-15,537
| -19% | -$835K | 0.65% | 31 |
|
|
2018
Q3 | $5.12M | Sell |
82,537
-1,289
| -2% | -$76.5K | 0.84% | 21 |
|
|
2018
Q2 | $4.64M | Buy |
83,826
+73,942
| +748% | +$3.99M | 0.81% | 22 |
|
|
2018
Q1 | $625K | Sell |
9,884
-2,533
| -20% | -$163K | 0.16% | 118 |
|
|
2017
Q4 | $761K | Buy |
12,417
+552
| +5% | +$34.5K | 0.18% | 123 |
|
|
2017
Q3 | $756K | Sell |
11,865
-1,746
| -13% | -$102K | 0.19% | 120 |
|
|
2017
Q2 | $758K | Buy |
13,611
+1,875
| +16% | +$102K | 0.2% | 116 |
|
|
2017
Q1 | $638K | Buy |
11,736
+6,278
| +115% | +$344K | 0.18% | 131 |
|
|
2016
Q4 | $319K | Buy |
5,458
+350
| +7% | +$19.1K | 0.13% | 149 |
|
|
2016
Q3 | $275K | Buy |
5,108
+900
| +21% | +$57.8K | 0.13% | 149 |
|
|
2016
Q2 | $9K | Buy |
+4,208
| New | +$297K | 0.02% | 159 |
|
Other funds holding BMY
Wintrust Investments's BMY Position: Q4 2024 in Review
Wintrust Investments reduced its Bristol-Myers Squibb (BMY) stake by 38% in Q4 2024, selling an estimated $84K and leaving 2,430 shares worth $137K. The position accounts for 0.12% of the portfolio, ranked #130.
Wintrust Investments first reported a position in BMY in Q2 2016 and has held it in 34 quarters since. The position peaked at $11.7M in Q1 2023. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Wintrust Investments held 2,430 shares of Bristol-Myers Squibb worth $137K as of Q4 2024.
- Wintrust Investments sold 1,504 Bristol-Myers Squibb shares in Q4 2024, an estimated $84K.
- Bristol-Myers Squibb made up 0.12% of Wintrust Investments's portfolio in Q4 2024, its #130 holding.
- Wintrust Investments first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 34 quarters since.
- Wintrust Investments's Bristol-Myers Squibb position peaked at $11.7M in Q1 2023.
- 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.